Overview
- On August 25, the High Court declined to halt trial court proceedings against the Gautam Gambhir Foundation, Gautam Gambhir and other trustees, and listed the matter for August 29.
- Justice Neena Bansal Krishna rebuked the defence for 'name‑dropping' and said the issue was whether there was a licence to distribute drugs, not the accused's public profile or relief work.
- An interim stay granted in September 2021 was vacated on April 9, and the defence sought its restoration ahead of the trial court’s next date on September 8.
- The Delhi Drugs Control Department’s complaint alleges unlicensed stocking and distribution of COVID‑19 medicines and oxygen during an April–May 2021 medical camp; accused include Gambhir, his wife Natasha, his mother Seema and CEO Aparajita Singh.
- The case cites Sections 18(c) and 27(b)(ii) of the Drugs and Cosmetics Act, and reporting notes earlier Delhi Police probes had given a clean chit even as the regulatory complaint proceeds.